Amylyx Pharmaceuticals, Inc. - AMLX
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Aug 20, 2026 | Chief Financial Officer | A | A | 22,807.0 | 0.0 | 0.0 | 244,435.0 | View | |
| Aug 20, 2026 | Co-Chief Executive Officer | A | A | 60,039.0 | 0.0 | 0.0 | 3,643,520.0 | View | |
| Aug 20, 2026 | Chief Legal Officer | A | A | 21,284.0 | 0.0 | 0.0 | 200,374.0 | View | |
| Aug 20, 2026 | Chief Medical Officer | A | A | 22,807.0 | 0.0 | 0.0 | 288,092.0 | View | |
| Aug 20, 2026 | Co-Chief Executive Officer | A | A | 60,039.0 | 0.0 | 0.0 | 3,643,587.0 | View | |
| Jul 13, 2026 | Chief Legal Officer | S | D | 15,000.0 | 17.6081 | 264,121.5 | 179,090.0 | View | |
| Jul 13, 2026 | Chief Legal Officer | S | D | 15,000.0 | 18.3164 | 274,746.0 | 194,090.0 | View | |
| Jun 08, 2026 | — | A | A | 24,372.0 | 0.0 | 0.0 | 24,372.0 | View | |
| Jun 08, 2026 | — | A | A | 24,372.0 | 0.0 | 0.0 | 24,372.0 | View | |
| Jun 08, 2026 | — | A | A | 24,372.0 | 0.0 | 0.0 | 24,372.0 | View | |
| Jun 08, 2026 | — | A | A | 24,372.0 | 0.0 | 0.0 | 24,372.0 | View | |
| Jun 08, 2026 | — | A | A | 24,372.0 | 0.0 | 0.0 | 24,372.0 | View | |
| May 26, 2026 | — | P | A | 3,800.0 | 13.51 | 51,338.0 | 66,900.0 | View | |
| Mar 09, 2026 | Co-Chief Executive Officer | A | A | 373,295.0 | 0.0 | 0.0 | 373,295.0 | View | |
| Mar 09, 2026 | Co-Chief Executive Officer | A | A | 248,865.0 | 0.0 | 0.0 | 3,583,481.0 | View | |
| Mar 09, 2026 | Chief Financial Officer | A | A | 143,985.0 | 0.0 | 0.0 | 143,985.0 | View | |
| Mar 09, 2026 | Chief Financial Officer | A | A | 95,990.0 | 0.0 | 0.0 | 261,628.0 | View | |
| Mar 09, 2026 | Chief Legal Officer | A | A | 111,990.0 | 0.0 | 0.0 | 111,990.0 | View | |
| Mar 09, 2026 | Chief Legal Officer | A | A | 74,660.0 | 0.0 | 0.0 | 209,090.0 | View | |
| Mar 09, 2026 | Co-Chief Executive Officer | A | A | 373,295.0 | 0.0 | 0.0 | 373,295.0 | View | |
| Mar 09, 2026 | Co-Chief Executive Officer | A | A | 248,865.0 | 0.0 | 0.0 | 3,583,548.0 | View | |
| Mar 09, 2026 | Chief Medical Officer | A | A | 143,985.0 | 0.0 | 0.0 | 143,985.0 | View | |
| Mar 09, 2026 | Chief Medical Officer | A | A | 95,990.0 | 0.0 | 0.0 | 265,285.0 | View | |
| Mar 04, 2026 | Chief Legal Officer | S | D | 6,844.0 | 14.5205 | 99,378.3 | 134,430.0 | View | |
| Mar 04, 2026 | Chief Financial Officer | S | D | 7,909.0 | 14.5216 | 114,851.33 | 165,638.0 | View | |
| Mar 04, 2026 | Chief Medical Officer | S | D | 6,461.0 | 14.5806 | 94,205.26 | 169,295.0 | View | |
| Mar 04, 2026 | Co-Chief Executive Officer | S | D | 29,282.0 | 14.484 | 424,120.49 | 3,334,683.0 | View | |
| Mar 04, 2026 | Co-Chief Executive Officer | S | D | 29,282.0 | 14.4717 | 423,760.32 | 3,334,616.0 | View |